Thomas J. Altree, Alison J. Pinczel, Barbara Toson, Kelly A. Loffler, Anna L. Hudson, Simon Proctor, Ganesh Naik, Sutapa Mukherjee, Peter Catcheside, Andrew Somogyi, David C. Currow, Danny J. Eckert
CHEST, Volume 167, Issue 6, June 2025, Pages 1578-1590, March 2025, Journal Ranking Q1, Impact Factor 9.2
Publication year: 2025
Background
Low-dose morphine may be prescribed to reduce chronic breathlessness in
COPD. Subjective findings suggest morphine may influence breathlessness through sleep-related mechanisms. However, concerns exist regarding opioid safety in
COPD. The effects of morphine during sleep in
COPD have not been objectively investigated. This study aimed to objectively determine the effects of low-dose morphine on sleep in
COPD.
Research Question
What are the effects of low-dose morphine on sleep efficiency and other sleep parameters in COPD?
Study Design and Methods
This was a randomized, double-anonymized, crossover trial of sustained-release morphine (20 mg/d for 3 days) (steady-state) vs placebo in 19 breathless people with COPD (n = 7 female participants). The primary outcome was sleep efficiency during in-laboratory overnight
polysomnography. Secondary and exploratory outcome measures included sleep-disordered breathing (events/h), oxygenation, transcutaneous CO
2 levels, blood and physiology biomarkers, the relationship between sleep and breathlessness, external resistive load responses, and driving simulator performance. Physiology outcomes and
pharmacokinetics were measured before and after each polysomnogram.
Results
Sleep efficiency was similar between placebo and morphine (66 ± 17% vs 67 ± 19%;
P = .89). Morphine did not change the frequency of sleep-disordered breathing events but reduced breathing frequency. Morphine reduced mean and nadir overnight
oxygen saturation by 2% (95% CI, –2.8% to –1.2%) and 5% (95% CI, –8% to –1%), respectively. Mean transcutaneous CO
2 was 3.3 mm Hg (95% CI, 1.6-5.1 mm Hg) higher during sleep with morphine vs placebo. Eight participants (42%) met American Academy of
Sleep Medicine criteria for nocturnal
hypoventilation with morphine vs four (21%) receiving placebo (
P = .02). Morphine did not systematically reduce breathlessness or impair next-day driving simulator performance.
Adverse events (most frequently nausea) were increased with morphine.
Interpretation
Steady-state, low-dose morphine does not change sleep efficiency, sleep-disordered breathing frequency, or next-day alertness but may cause
hypoventilation during sleep, a potentially harmful effect.